HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)

SHA:600829 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	883.88	1,235	1,100	1,314	1,181	800.49
Cash & Short-Term Investments	883.88	1,235	1,100	1,314	1,181	800.49
Cash Growth	18.54%	12.33%	-16.32%	11.25%	47.59%	91.18%
Accounts Receivable	4,565	4,086	4,350	4,385	4,168	4,182
Other Receivables	20.01	61.11	53.13	64.96	47.26	40.91
Receivables	4,585	4,147	4,403	4,450	4,215	4,222
Inventory	1,282	1,230	1,101	1,115	1,074	1,105
Prepaid Expenses	-	4.76	9.98	1.79	4.59	8.44
Other Current Assets	119.19	75.27	72.83	42.8	71.01	48.78
Total Current Assets	6,870	6,693	6,687	6,925	6,546	6,185
Property, Plant & Equipment	318.09	318.06	335.85	346.13	367.81	410.84
Other Intangible Assets	25.83	26.34	28.08	26.5	28.01	29.29
Long-Term Deferred Tax Assets	87.17	83.43	67.45	67.69	64.25	67.15
Long-Term Deferred Charges	8.01	8.93	10.48	11.2	11.81	12.08
Other Long-Term Assets	44.28	44.96	37.42	50.3	40.54	43.14
Total Assets	7,353	7,175	7,166	7,426	7,059	6,748

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2,939	2,836	2,781	2,914	2,614	2,478
Accrued Expenses	15.87	45.82	34.24	44.73	50.24	30.72
Short-Term Debt	706.8	679.4	839.22	962.08	1,198	1,233
Current Portion of Leases	24.61	24.89	30.56	27.69	32.09	35.18
Current Income Taxes Payable	57.19	26.96	25.84	43.33	27.38	34.92
Current Unearned Revenue	15.76	23.97	15.12	15.99	11.45	13.3
Other Current Liabilities	390.73	378.08	408.3	512.7	498.47	531.72
Total Current Liabilities	4,150	4,015	4,134	4,521	4,431	4,357
Long-Term Leases	23.78	28.08	30.37	29.41	38.48	59.59
Long-Term Unearned Revenue	112.66	113.63	117.09	120.94	125.71	130.77
Long-Term Deferred Tax Liabilities	2.97	3.31	3.7	4.05	4.51	-
Other Long-Term Liabilities	-	-	-	0.14	0.57	1.56
Total Liabilities	4,290	4,160	4,285	4,675	4,601	4,549

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	579.89	579.89	579.89	579.89	579.89	579.89
Retained Earnings	2,484	2,435	2,301	2,172	1,879	1,620
Total Common Equity	3,063	3,015	2,881	2,751	2,459	2,200
Minority Interest	-0.04	-0.04	-0.04	-0.04	-1.06	-1.02
Shareholders' Equity	3,063	3,015	2,881	2,751	2,458	2,199
Total Liabilities & Equity	7,353	7,175	7,166	7,426	7,059	6,748

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	755.18	732.37	900.15	1,019	1,268	1,328
Net Cash (Debt)	128.69	503.04	199.69	295.17	-86.9	-527.08
Net Cash Growth	-	151.91%	-32.35%	-	-	-
Net Cash Per Share	0.22	0.87	0.34	0.51	-0.15	-0.91
Filing Date Shares Outstanding	579.89	579.89	579.89	579.89	579.89	579.89
Total Common Shares Outstanding	579.89	579.89	579.89	579.89	579.89	579.89
Working Capital	2,719	2,678	2,553	2,404	2,115	1,829
Book Value Per Share	5.28	5.20	4.97	4.74	4.24	3.79
Tangible Book Value	3,038	2,989	2,853	2,725	2,431	2,171
Tangible Book Value Per Share	5.24	5.15	4.92	4.70	4.19	3.74
Buildings	-	357.93	372.04	372.04	374.91	374.93
Machinery	-	153.62	145.84	147.21	146.43	149.73
Construction In Progress	-	55.27	57.47	59.62	60.42	60.42

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 29, 2026

Data Sources Report a data error